GPAC: Global Partner Acquisition Corp II Stock

by  •  • Comments Off on GPAC: Global Partner Acquisition Corp II Stock

SIC 28 – Chemicals And Allied Products

Valuation
Market Cap ($M) 0.00
Enterprise Value ($M) 3.46
Book Value ($M) -18.67
Book Value / Share -2.01
Price / Book 0.00
NCAV ($M) -62.38
NCAV / Share -6.71
Price / NCAV 0.00

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) 0.00
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.00
Current Ratio 0.00

Balance Sheet (mrq) ($M)
Current Assets 0.04
Assets 43.74
Liabilities 62.41
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -5.23
Net Income 0.14
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -0.97
Cash from Investing 263.25
Cash from Financing -262.35

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
03-07 13G/A Vivaldi Asset Management, LLC 0.00 -100.00
02-14 13G/A Glazer Capital, Llc 5.46 -22.57
02-14 13G Rivernorth Capital Management, Llc 5.86
02-14 13G Meteora Capital, LLC 8.41
02-14 13G Fir Tree Capital Management Lp 9.68
02-12 13G/A Aristeia Capital Llc 0.00 -100.00
02-12 13G LMR Partners LLP 6.40
02-09 13G Periscope Capital Inc. 5.10
02-02 13G/A Cowen Financial Products LLC 5.09 0.00
01-08 13G Atlas Merchant Capital LLC 5.10

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-19 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUA
2023-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT
2023-08-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO S
2023-05-16 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-16 80 7,310 1.09

(click for more detail)

Similar Companies
GNLX – Genelux Corporation GNPX – Genprex, Inc.
GOVX – GeoVax Labs, Inc. GTBP – GT Biopharma, Inc.
GYRE – Gyre Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io